Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

Safety and Tolerability of ODM-201 in Patients With Castrate Resistant Prostate Cancer: Open, Non-randomised, Uncontrolled, Multicentre, Extension Study to Study 3104001

The purpose of this study is to evaluate safety and tolerability of ODM-201 in patients with castrate resistant prostate cancer.

Inclusion Criteria:

• Written informed consent
• Successful completion of study protocol 3104001
• Response or stable disease in study 3104001 at week 12

Exclusion Criteria:

• New serious concurrent medical condition
• Not able to swallow the study drug